Trade

with

Alexza Pharmaceuticals Inc
(NASDAQ: ALXA)
AdChoices
2.21
+0.13
+6.25%
After Hours :
-
-
-

Open

2.16

Previous Close

2.08

Volume (Avg)

67.15k (149.63k)

Day's Range

2.12-2.26

52Wk Range

1.99-5.93

Market Cap.

36.13M

Dividend Rate ( Yield )

-

Beta

1.27

Shares Outstanding

17.37M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 47.84M

    • Net Income

    • -39.62M

    • Market Cap.

    • 36.13M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -488.44

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.27

    • Forward P/E

    • -1.35

    • Price/Sales

    • 5.36

    • Price/Book Value

    • -1.06

    • Price/Cash flow

    • -0.84

      • EBITDA

      • -34.79M

      • Return on Capital %

      • -52.60

      • Return on Equity %

      • -

      • Return on Assets %

      • -52.60

      • Book Value/Share

      • -2.09

      • Shares Outstanding

      • 17.37M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/20/2014
      Hold
        • 1 Year Price Target

        • 5.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -1.56

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -96.60

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 150.40

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -137.78

            • 64.72

            • Pre-Tax Margin

            • -488.44

            • 13.77

            • Net Profit Margin

            • -488.44

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 95.30

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -515.80

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.33

              • Current Ratio

              • 5.31

              • 1.52

              • Quick Ratio

              • 4.60

              • 0.87

              • Interest Coverage

              • -7.91

              • 6.77

              • Leverage Ratio

              • -

              • 1.91

              • Book Value/Share

              • -2.09

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.10

                • 63.69

                • P/E Ratio 5-Year High

                • -19.47

                • 237.47

                • P/E Ratio 5-Year Low

                • -0.99

                • 19.71

                • Price/Sales Ratio

                • 5.36

                • 3.57

                • Price/Book Value

                • -1.06

                • 3.35

                • Price/Cash Flow Ratio

                • -0.84

                • 21.41

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -

                        (-)

                      • 7.86

                        (9.58)

                      • Return on Assets %

                        (5-Year Average)

                      • -52.60

                        (-76.70)

                      • 4.14

                        (5.54)

                      • Return on Capital %

                        (5-Year Average)

                      • -

                        (-)

                      • 5.59

                        (7.66)

                      • Income/Employee

                      • -

                      • 27.79k

                      • Inventory Turnover

                      • 6.45

                      • 1.80

                      • Asset Turnover

                      • 0.11

                      • 0.38

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      1.77M
                      Operating Margin
                      3.70
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -0.84
                      Ownership

                      Institutional Ownership

                      51.72%

                      Top 10 Institutions

                      41.69%

                      Mutual Fund Ownership

                      15.81%

                      Float

                      98.55%

                      5% / Insider Ownership

                      4.30%

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Swedbank Robur Medica

                      •  

                        852,000

                      • 0.00

                      • 5.02

                      • Carnegie Global Healthcare

                      •  

                        593,580

                      • 0.00

                      • 3.53

                      • Vanguard Total Stock Mkt Idx

                      •  

                        425,033

                      • 0.00

                      • 2.45

                      • AST Federated Aggressive Growth

                      •  

                        141,912

                      • -59.43

                      • 0.82

                      • Carnegie Biotechnology

                      •  

                        122,000

                      • 0.00

                      • 0.72

                      • Vanguard Extended Market Index Fund

                      •  

                        114,088

                      • 11.26

                      • 0.66

                      • Top Alpha Overseas Equity

                      •  

                        93,191

                      • -54.57

                      • 0.54

                      • Vanguard Instl Total Stock Market Index

                      •  

                        81,627

                      • 0.00

                      • 0.47

                      • iShares Micro-Cap

                      •  

                        63,618

                      • 1.28

                      • 0.33

                      • Bridgeway Ultra Small Company Market

                      •  

                        50,000

                      • 0.00

                      • 0.29

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • LANSDOWNE PARTNERS AUSTRIA GMBH

                      •  

                        1,426,235

                      • +5.24%

                      • 8.23

                      • Swedbank Robur Fonder AB

                      •  

                        852,000

                      • 0.00%

                      • 5.02

                      • Morgan Stanley & Co Inc

                      •  

                        841,247

                      • +12.04%

                      • 4.86

                      • Credit Suisse First Boston (CSFB)

                      •  

                        790,355

                      • -0.04%

                      • 4.56

                      • Credit Suisse Asset Management, LLC

                      •  

                        780,133

                      • -6.19%

                      • 4.51

                      • Carnegie Asset Management Fondsmæglersel

                      •  

                        715,580

                      • 0.00%

                      • 4.25

                      • Goldman, Sachs & Co.

                      •  

                        486,629

                      • +6.32%

                      • 2.81

                      • Vanguard Group, Inc.

                      •  

                        406,824

                      • +1.49%

                      • 2.35

                      • VHCP Management, LLC

                      •  

                        247,812

                      • 0.00%

                      • 1.43

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Drug Manufacturers – Specific & Generic

                      Type

                      Speculative Growth

                      Style

                      Small Growth

                      Alexza Pharmaceuticals, Inc. was incorporated in the state of Delaware on December 19, 2000 as FaxMed, Inc. In June 2001, it changed the name to Alexza Corporation and in December 2001 it became Alexza Molecular Delivery Corporation....more In July 2005, it changed the name to Alexza Pharmaceuticals, Inc. It is a pharmaceutical company, engaged in the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. ADASUVE is its only approved product & there is one product candidate in active development, AZ-002 (Staccato alprazolam), which is being developed for the treatment of acute repetitive seizures, sometimes called cluster seizures or ARS. ADASUVE, or Staccato loxapine, and its product candidates are based on its proprietary te...morechnology, the Staccato system. The Staccato system vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. Because of the particle size of the aerosol, the drug is quickly absorbed through the deep lung into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous, or IV, administration but with greater ease, patient comfort and convenience. The pharmaceutical and biotechnology industries are intensely competitive. Many pharmaceutical companies, biotechnology companies, public and private universities, government agencies and research organizations are actively engaged in research and development of products targeting the same markets as ADASUVE and its other product candidates. The names “Alexza Pharmaceuticals,” “Alexza,” “Staccato” and “ADASUVE” are trademarks of the Company. It helds 195 issued and allowed U.S. and international patents. The testing, manufacturing, labeling, advertising, promotion, distribution, export and marketing of the Company’s product candidates are subject to extensive regulation by governmental authorities in the United States and other countries.lessless

                      Key People

                      Thomas B. King

                      CEO/President/Director

                      Mr. Mark K. Oki

                      CFO/Chief Accounting Officer/Secretary/Senior VP, Divisional

                      Mr. Robert A. Lippe

                      COO/Executive VP, Divisional

                      Dr. James V. Cassella,PhD

                      Chief Scientific Officer/Executive VP, Divisional

                      Dr. J. Leighton Read,M.D.

                      Director

                      • Alexza Pharmaceuticals Inc

                      • 2091 Stierlin Court

                      • Mountain View, CA 94043

                      • USA.Map

                      • Phone: +1 650 944-7000

                      • Fax: +1 650 944-7999

                      • alexza.com

                      Incorporated

                      2000

                      Employees

                      90

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: